About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Receipt of R&D Tax Incentive

November 27, 2018

Click here to read more

Post navigation

Phosphagenics Arbitration Award Issued

Voluntary Withdrawal from OTCQX

Related Posts

Phosphagenics Signs Term Sheet for TPM Diclofenac Gel in Asia

September 26, 2017

Mylan Arbitration Update – expert report on quantum of damages claimed filed

May 29, 2017

Phosphagenics Placement Secures A$1.37 million

January 18, 2018

Recent Posts

Peak TV Interview
May 31, 2021
Animal Health Update
May 31, 2021
Cannabiz: The long and winding road to S3 registration
May 27, 2021

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.